Less than a year after an acquisition that doubled the headcount and nearly quadrupled the expected revenue for Waltham-based Amag Pharmaceuticals, CEO Bill Heiden says he’s already looking forward to doing it again.
Amag (Nasdaq: AMAG) was incorporated in 1981, and has been traded on the Nasdaq since 2006, but its shares have been trading at an all-time high for most of the past month, the result of a steady rise since its purchase last September of Lumara Health. That Chesterfield, Mo. company makes an approved drug to prevent pre-term birth called Makena that had sales of $130 million in the year that ended shortly before Amag bought it for more than $1 billion, including milestones.
Help employers find you! Check out all the jobs and post your resume.
Amag (Nasdaq: AMAG) was incorporated in 1981, and has been traded on the Nasdaq since 2006, but its shares have been trading at an all-time high for most of the past month, the result of a steady rise since its purchase last September of Lumara Health. That Chesterfield, Mo. company makes an approved drug to prevent pre-term birth called Makena that had sales of $130 million in the year that ended shortly before Amag bought it for more than $1 billion, including milestones.
Help employers find you! Check out all the jobs and post your resume.
